Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | ESR1 | P03372 | 2/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | METAP1 | P53582 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | TOP1 | P11387 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29412194 | 1.00 | KMT2A (0.59) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL28565017 | 0.91 | ALDH1A1 (0.56) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL10924560 | 0.89 | KMT2A (0.47) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL3760693 | 0.88 | NPSR1 (0.58) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL10919965 | 0.88 | ESR1 (0.51) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL28321543 | 0.86 | POLB (0.59) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL2510100 | 0.86 | MAPT (0.53) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL16241898 | 0.85 | KMT2A (0.59) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL6668242 | 0.85 | KMT2A (0.59) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 | |
| SCHEMBL8778657 | 0.85 | THRA (0.56) | KMT2AMAPTSMN1; SMN2SLC6A3NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 611 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094649-A | Personal care compositions | — | 2026-05-26 | — | — | CN | claimed |
| US-12440434-B2 | Cosmetic composition providing unique sensations | L'OREAL (FR) | 2025-10-14 | — | — | US | claimed |
| US-12303576-B2 | Two phase water-based smudge-resistant make-up remover | L'OREAL (FR) | 2025-05-20 | — | — | US | claimed |
| WO-2025054445-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-13 | — | — | WO | claimed |
| US-20250073142-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-06 | — | — | US | claimed |
| EP-4486289-A1 | COMPOSITIONS AND METHODS FOR CURLY HAIR | L'OREAL (FR) | 2025-01-08 | — | — | EP | claimed |
| US-12115239-B2 | Cosmetic compositions, kits thereof, and methods for making and using the same | L'OREAL (FR) | 2024-10-15 | — | — | US | claimed |
| CN-117956967-A | Cosmetic preparation containing high specific gravity soda-lime glass beads | 拜尔斯道夫股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| EP-4346747-A1 | COSMETIC COMPOSITION COMPRISING VITAMIN C | L'OREAL (FR) | 2024-04-10 | — | — | EP | claimed |
| US-20240074956-A1 | COSMETIC COMPOSITIONS, KITS THEREOF, AND METHODS FOR MAKING AND USING THE SAME | L'OREAL (FR) | 2024-03-07 | — | — | US | claimed |
| US-20060134037-A1 | Antiperspirant or deodorant compositions | CONOPCO INC, D/B/A UNILEVER | 2006-06-22 | — | — | US | claimed |
| CN-1753918-A | Polymer without long branched chain | EXXONMOBIL CHEM PATENTS INC (US) | 2006-03-29 | — | — | CN | claimed |
| CN-1738843-A | Polymers with novel sequence distributions | EXXONMOBIL CHEM PATENTS INC (US) | 2006-02-22 | — | — | CN | claimed |
| CN-1738836-A | Polymerization process | EXXONMOBIL CHEM PATENTS INC (US) | 2006-02-22 | — | — | CN | claimed |
| CN-1729204-A | Polymerization processes | EXXONMOBIL CHEM PATENTS INC (US) | 2006-02-01 | — | — | CN | claimed |
| CN-1729209-A | Polymerization processes | EXXONMOBIL CHEM PATENTS INC (US) | 2006-02-01 | — | — | CN | claimed |
| CN-1729215-A | Polymers with new sequence distributions | EXXONMOBIL CHEM PATENTS INC (US) | 2006-02-01 | — | — | CN | claimed |
| CN-1729208-A | Polymerization processes | EXXONMOBIL CHEM PATENTS INC (US) | 2006-02-01 | — | — | CN | claimed |
| EP-1572766-A1 | POLYMERS WITH NEW SEQUENCE DISTRIBUTIONS | ExxonMobil Chemical Patents Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| WO-2004058836-A1 | POLYMERS WITH NEW SEQUENCE DISTRIBUTIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-07-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12115239-B2 | Cosmetic compositions, kits thereof, and methods for making and using the same | CUTA, LIPC, MGLL | KMT2A 2240/4885MAPT 2333/4885SMN1; SMN2 4208/4885 |
| US-20060134037-A1 | Antiperspirant or deodorant compositions | DECR1, ADH1A, GDI2 | KMT2A 3849/4885MAPT 307/4885SMN1; SMN2 3851/4885 |
| US-20240074956-A1 | COSMETIC COMPOSITIONS, KITS THEREOF, AND METHODS FOR MAKING AND USING THE SAME | CUTA, LIPC, MGLL | KMT2A 2240/4885MAPT 2333/4885SMN1; SMN2 4208/4885 |
| US-20250073142-A1 | Personal Care Compositions | CUTA, PROC, TTPA | KMT2A 3148/4885MAPT 1916/4885SMN1; SMN2 1738/4885 |
| US-12440434-B2 | Cosmetic composition providing unique sensations | CUTA, LRBA, FABP4 | KMT2A 2154/4885MAPT 1333/4885SMN1; SMN2 2558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.